Clinical Trials Browser

Glioblastoma

NCT06618703 2026-04-06

BIChE-1

Phase NA Recruiting

230 enrolled

CNS

Brain Neoplasms, Radiation Injuries

NCT05805631 2026-03-24

Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC

Phase 2 Recruiting

23 enrolled

CNSThoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT05954416 2026-02-12

FARD

Recruiting

900 enrolled

CNS

Albinism, Ectodermal Dysplasia, Ichthyosis, Incontinentia Pigmenti, Keratoderma, Palmoplantar, Neurofibromatosis 1, Pemphigoid, Benign Mucous Membrane, Pemphigus

NCT07272616 2026-01-30

GDW

Recruiting

100 enrolled

CNS

Brain Neoplasms

NCT06898684 2025-12-16

MOVE

Phase NA Recruiting

15 enrolled

CNS

Medulloblastoma, Motor Activity

NCT07264569 2025-12-04

Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001

Phase 1/2 Recruiting

42 enrolled

CNS

Meningeal Carcinomatosis

NCT07224451 2025-11-04

BDF002

Phase NA Recruiting

20 enrolled

CNS

Spinal Cord Neoplasms

NCT07100600 2025-08-11

Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases

Phase 2 Recruiting

224 enrolled

CNS

Brain Neoplasms

NCT05474573 2025-05-16

CONFLUENSE

Phase NA Recruiting

52 enrolled

CNS

Brain Neoplasms, Glioma

NCT05477680 2025-05-16

BRASH

Phase NA Recruiting

100 enrolled

CNS

Arteriovenous Malformations, Brain Neoplasms, Cerebral Hemorrhage, Neoplasms, Hemangioma, Capillary

NCT05484245 2025-05-16

SOMALI

Phase NA Recruiting

100 enrolled

CNS

Arteriovenous Malformations, Brain Neoplasms, Cerebral Hemorrhage, Hemangioma, Capillary

NCT05700071 2025-03-20

GLIOMRS

Phase NA Recruiting

80 enrolled

CNS

Disease, Glioma

NCT06643000 2025-03-06

Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis

Phase NA Recruiting

60 enrolled

CNSThoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT06051240 2024-04-12

LiBRA

Phase 2 Recruiting

84 enrolled

CNS

Brain Neoplasms, Memory Disorders, Radiation Injuries, Cognitive Dysfunction

NCT05982691 2023-08-08

Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors

Recruiting

400 enrolled

CNS

Central Nervous System Neoplasms, Germinoma

Clinical Trials

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

BIChE-1

Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC

FARD

GDW

MOVE

Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001

BDF002

Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases

CONFLUENSE

BRASH

SOMALI

GLIOMRS

Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis

LiBRA

Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors